Corcept Therapeutics (CORT) PT Raised to $45 at Ladenburg Thalmann
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $23.26 +1.39%
Rating Summary:
9 Buy, 6 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 21 | New: 16
Rating Summary:
9 Buy, 6 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 21 | New: 16
Join SI Premium – FREE
Ladenburg Thalmann analyst Matt Kaplan raised the price target on Corcept Therapeutics (NASDAQ: CORT) to $45.00 (from $35.00) while maintaining a Buy rating.
You May Also Be Interested In
- Cie de Saint-Gobain (SGO:FP) (CODYY) PT Raised to EUR70 at JPMorgan
- Travis Perkins (TPK:LN) (TPRKY) PT Raised to GBP8.20 at JPMorgan
- Sika AG (SIKA:SW) (SKFOF) PT Raised to CHF216 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
